These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7076348)

  • 1. Relationship between quinidine concentrations measured in saliva and erythrocytes, and in serum.
    Yosselson-Superstine S; Yanuka Y; Ishai S
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):181-6. PubMed ID: 7076348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the verapamil concentration of human blood serum and saliva].
    Rumiantsev DO; Piotrovskiĭ VK; Riabokon' OS; Metelitsa VI
    Farmakol Toksikol; 1987; 50(1):85-9. PubMed ID: 3556560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state serum quinidine concentration: role in prophylactic therapy following acute myocardial infarction.
    Halkin H; Vered Z; Millman P; Rabinowitz B; Neufeld HN
    Isr J Med Sci; 1979 Jul; 15(7):583-7. PubMed ID: 478822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diurnal oscillations in the serum and salivary levels of quinidine.
    Rao BR; Rambhau D
    Arzneimittelforschung; 1995 Jun; 45(6):681-3. PubMed ID: 7646570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinidine saliva concentrations: absence of correlation with serum concentrations at steady state.
    Narang PK; Carliner NH; Fisher ML; Crouthamel WG
    Clin Pharmacol Ther; 1983 Nov; 34(5):695-702. PubMed ID: 6627830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered protein binding of quinidine in patients with atrial fibrillation and flutter.
    McCollam PL; Crouch MA; Watson JE
    Pharmacotherapy; 1997; 17(4):753-9. PubMed ID: 9250553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratios of free to total prostate-specific antigen and total prostate specific antigen to protein concentrations in saliva and serum of healthy men.
    Ayatollahi H; Darabi Mahboub MR; Mohammadian N; Parizadeh MR; Kianoosh T; Khabbaz Khoob M; Kamalian F
    Urol J; 2007; 4(4):238-41. PubMed ID: 18270950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disopyramide concentrations in saliva.
    Aitio ML; Virtanen R; Lammintausta R
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):68-72. PubMed ID: 7061181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saliva lithium: a poor predictor of plasma and erythrocyte levels.
    McKeage MJ; Maling TJ
    N Z Med J; 1989 Oct; 102(878):559-60. PubMed ID: 2812583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Saliva phenobarbital concentration in epileptics].
    Shen D
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Dec; 22(6):369-70, 382. PubMed ID: 2638994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of plasma protein binding on quinidine kinetics in the rabbit.
    Guentert TW; Oie S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):165-71. PubMed ID: 7452481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV infection, as opposed to antiretroviral therapy, does not cause changes in the concentration levels of specific salivary electrolytes.
    Biocina-Lukenda D; Blazić-Potocki Z; Lukenda J; Potocki-Karacić T
    Coll Antropol; 2009 Mar; 33(1):93-7. PubMed ID: 19408610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monitoring serum theophylline levels in children. Use of saliva for prediction].
    Dolezalová K; Martínková J; Kopecká J; Kuralová Z; Etlerová E
    Cesk Pediatr; 1989 Oct; 44(10):592-6. PubMed ID: 2620353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary theophylline monitoring in asthmatic children.
    Orłowski L; Paczkowski D; Podleśny J
    Pol J Pharmacol Pharm; 1987; 39(2):173-6. PubMed ID: 3432165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid elimination of quinidine in pediatric patients.
    Szefler SJ; Pieroni DR; Gingell RL; Shen DD
    Pediatrics; 1982 Sep; 70(3):370-5. PubMed ID: 7110810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular risk markers in hemodialysis].
    Urso S; Milone F; Garozzo M; Cannavò ME; Biondi A; Battaglia G
    G Ital Nefrol; 2004; 21 Suppl 30():S212-6. PubMed ID: 15750988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between saliva and serum quinidine concentrations and suppression of ventricular premature beats.
    Ueda CT; Beckmann PJ; Dzindzio BS
    Ther Drug Monit; 1984; 6(1):43-9. PubMed ID: 6200964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability and predictive value of salivary theophylline levels.
    Jaber M; Schneider AT; Goldstein S; Sergiou H; Bjornson L; Chiaramonte LT
    Ann Allergy; 1987 Feb; 58(2):105-8. PubMed ID: 3813126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva-serum theophylline concentrations: substantial intrapatient and interpatient variation in predicting serum concentrations.
    Uden DL; Miller KW; Strand LM; Johnson PB; Zaske DE
    Ther Drug Monit; 1981; 3(2):143-50. PubMed ID: 7268827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.